These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 33952804)
1. The E2F transcription factor 2: What do we know? Li L; Wang S; Zhang Y; Pan J Biosci Trends; 2021 May; 15(2):83-92. PubMed ID: 33952804 [TBL] [Abstract][Full Text] [Related]
2. The role of E2F2 in cancer progression and its value as a therapeutic target. Gao Y; Qiao X; Liu Z; Zhang W Front Immunol; 2024; 15():1397303. PubMed ID: 38807594 [TBL] [Abstract][Full Text] [Related]
3. Increased metastasis with loss of E2F2 in Myc-driven tumors. Yuwanita I; Barnes D; Monterey MD; O'Reilly S; Andrechek ER Oncotarget; 2015 Nov; 6(35):38210-24. PubMed ID: 26474282 [TBL] [Abstract][Full Text] [Related]
4. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer. Li H; Zhao S; Shen L; Wang P; Liu S; Ma Y; Liang Z; Wang G; Lv J; Qiu W Aging (Albany NY); 2021 Apr; 13(10):13626-13643. PubMed ID: 34091441 [TBL] [Abstract][Full Text] [Related]
5. Transcription factor compensation during mammary gland development in E2F knockout mice. To B; Andrechek ER PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434 [TBL] [Abstract][Full Text] [Related]
6. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2. Chen Q; Hung FC; Fromm L; Overbeek PA Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619 [TBL] [Abstract][Full Text] [Related]
7. Low E2F2 activity is associated with high genomic instability and PARPi resistance. Rennhack JP; Andrechek ER Sci Rep; 2020 Oct; 10(1):17948. PubMed ID: 33087787 [TBL] [Abstract][Full Text] [Related]
8. E2F2 represses cell cycle regulators to maintain quiescence. Infante A; Laresgoiti U; Fernández-Rueda J; Fullaondo A; Galán J; Díaz-Uriarte R; Malumbres M; Field SJ; Zubiaga AM Cell Cycle; 2008 Dec; 7(24):3915-27. PubMed ID: 19066456 [TBL] [Abstract][Full Text] [Related]
9. miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer. Feliciano A; Garcia-Mayea Y; Jubierre L; Mir C; Hummel M; Castellvi J; Hernández-Losa J; Paciucci R; Sansano I; Sun Y; Ramón Y Cajal S; Kondon H; Soriano A; Segura M; Lyakhovich A; LLeonart ME Cell Death Dis; 2017 Oct; 8(10):e3141. PubMed ID: 29072692 [TBL] [Abstract][Full Text] [Related]
10. B-Myb accelerates colorectal cancer progression through reciprocal feed-forward transactivation of E2F2. Fan X; Wang Y; Jiang T; Liu T; Jin Y; Du K; Niu Y; Zhang C; Liu Z; Lei Y; Bu Y Oncogene; 2021 Sep; 40(37):5613-5625. PubMed ID: 34316028 [TBL] [Abstract][Full Text] [Related]
11. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism. Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258 [TBL] [Abstract][Full Text] [Related]
12. E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells. Castillo DS; Campalans A; Belluscio LM; Carcagno AL; Radicella JP; Cánepa ET; Pregi N Cell Cycle; 2015; 14(8):1300-14. PubMed ID: 25892555 [TBL] [Abstract][Full Text] [Related]
13. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Opavsky R; Tsai SY; Guimond M; Arora A; Opavska J; Becknell B; Kaufmann M; Walton NA; Stephens JA; Fernandez SA; Muthusamy N; Felsher DW; Porcu P; Caligiuri MA; Leone G Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15400-5. PubMed ID: 17881568 [TBL] [Abstract][Full Text] [Related]
15. Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2. Wang H; Zhang X; Liu Y; Ni Z; Lin Y; Duan Z; Shi Y; Wang G; Li F Oncotarget; 2016 Jun; 7(24):36577-36589. PubMed ID: 27174918 [TBL] [Abstract][Full Text] [Related]
16. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Murga M; Fernández-Capetillo O; Field SJ; Moreno B; Borlado LR; Fujiwara Y; Balomenos D; Vicario A; Carrera AC; Orkin SH; Greenberg ME; Zubiaga AM Immunity; 2001 Dec; 15(6):959-70. PubMed ID: 11754817 [TBL] [Abstract][Full Text] [Related]
17. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Müller H; Bracken AP; Vernell R; Moroni MC; Christians F; Grassilli E; Prosperini E; Vigo E; Oliner JD; Helin K Genes Dev; 2001 Feb; 15(3):267-85. PubMed ID: 11159908 [TBL] [Abstract][Full Text] [Related]
18. E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3. Chen D; Chen Y; Forrest D; Bremner R Cell Death Differ; 2013 Jul; 20(7):931-40. PubMed ID: 23558950 [TBL] [Abstract][Full Text] [Related]
19. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Chong JL; Wenzel PL; Sáenz-Robles MT; Nair V; Ferrey A; Hagan JP; Gomez YM; Sharma N; Chen HZ; Ouseph M; Wang SH; Trikha P; Culp B; Mezache L; Winton DJ; Sansom OJ; Chen D; Bremner R; Cantalupo PG; Robinson ML; Pipas JM; Leone G Nature; 2009 Dec; 462(7275):930-4. PubMed ID: 20016602 [TBL] [Abstract][Full Text] [Related]
20. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis. Huang JW; Luo XY; Li ZH; Lang BP Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]